FIELD: chemistry.
SUBSTANCE: invention includes a granulated composition containing an active ingredient (S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide, where total amount of active ingredient contains by weight in % approximately 60–90 % of form 1 HCl (S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide, approximately 10–30 % amorphous HCl (S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide and approximately 0–5 % amorphous free base (S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide, and additives. Described also is a method of producing a granular composition.
EFFECT: disclosed composition minimizes disproportionation of the initial crystalline form with wet granulation.
5 cl, 4 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SPIROCYCLIC COMPOUNDS | 2016 |
|
RU2745069C2 |
| N-[(1H-PYRAZOL-1-YL) ARYL]-1H-INDOLE OR 1H-INDAZOLE-3-CARBOXAMIDE DERIVATIVES, PRODUCING AND USING THEM AS P2Y12 ANTAGONISTS | 2011 |
|
RU2572593C2 |
| N-(1-(1-BENZYL-4-PHENYL-1H-IMIDAZOL-2-YL)-2,2-DIMETHYLPROPYL)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS KINESIN SPINDLE PROTEIN (KSP) INHIBITORS FOR TREATING CANCER | 2005 |
|
RU2427572C2 |
| NEW CRYSTALLINE FORM OF 2-{3-[2-(1-{[3,5-BIS(DIFLUOROMETHYL)-1H-PYRAZOL-1-YL]ACETYL}PIPERIDIN-4-YL)-1,3-THIAZOL-4-YL]-4,5-DIHYDRO-1,2-OXAZOL-5-YL}-3-CHLOROPHENYLMETHANE SULPHONATE | 2014 |
|
RU2691948C2 |
| 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES | 2020 |
|
RU2822388C2 |
| COMPOUNDS OF SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZOL [1,2-a]-3-CARBOXAMIDE AS cFMS INHIBITORS | 2010 |
|
RU2562977C2 |
| ESTER PRODRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL]METHANOL | 2011 |
|
RU2612351C2 |
| THIAZOLPYRIMIDINES | 2012 |
|
RU2610840C2 |
| DERIVATIVES OF 1H-1,2,4-TRIAZOLE-3-CARBOXAMIDEAS LIGANDS OF RECEPTOR CANNABINOIDS | 2003 |
|
RU2325382C2 |
| N-(1H-IMIDAZOL-2-YL)BENZAMIDE AND PHARMACEUTICAL COMPOSITION CONTAINING IT AS ACTIVE INGREDIENT | 2020 |
|
RU2806754C1 |
